Verastem (VSTM, Financial) has announced a conference call slated for May 1 at 11 a.m., featuring its President & CEO, Paterson, along with Chief Scientific Officer, Pachter. The session will be facilitated by Cantor Fitzgerald and will also be available through a webcast link. This call is expected to provide insights into the company's strategic direction and scientific advancements.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 8 analysts, the average target price for Verastem Inc (VSTM, Financial) is $13.38 with a high estimate of $20.00 and a low estimate of $8.00. The average target implies an upside of 82.72% from the current price of $7.32. More detailed estimate data can be found on the Verastem Inc (VSTM) Forecast page.
Based on the consensus recommendation from 9 brokerage firms, Verastem Inc's (VSTM, Financial) average brokerage recommendation is currently 1.7, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
